Abnormal neurodevelopment, neurosignaling and behaviour in Npas3-deficient mice

被引:60
作者
Brunskill, EW
Ehrman, LA
Williams, MT
Klanke, J
Hammer, D
Schaefer, TL
Sah, R
Dorn, GW
Potter, SS
Vorhees, CV
机构
[1] Univ Cincinnati, Coll Med, Div Cardiol, Cincinnati, OH 45267 USA
[2] Univ Cincinnati, Coll Med, Cincinnati, OH 45229 USA
[3] Cincinnati Childrens Res Fdn, Div Dev Biol, Cincinnati, OH 45229 USA
[4] Cincinnati Childrens Res Fdn, Div Child Neurol, Cincinnati, OH 45229 USA
[5] Univ Cincinnati, Coll Med, Dept Psychiat, Cincinnati, OH 45267 USA
关键词
behavioural abnormalities; bHLH-PAS; brain development; developing neuroepithelium; developmental abnormalities; PSD-95;
D O I
10.1111/j.1460-9568.2005.04291.x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Npas3 is a member of the bHLH-PAS superfamily of transcription factors that is expressed broadly in the developing neuroepithelium. To study the function of this gene, mice deficient in Npas3 were generated and characterized. Npas3(-/-) mice were growth-retarded and exhibited developmental brain abnormalities that included a reduction in size of the anterior hippocampus, hypoplasia of the corpus callosum and enlargement of the ventricles. A number of behavioural abnormalities were identified in Npas3(-/-) mice including locomotor hyperactivity, subtle gait defects, impairment of prepulse inhibition of acoustic startle, deficit in recognition memory and altered anxiety-related responses. Characterization of neurosignaling pathways using several pharmacological agents revealed dysfunctional glutamate, dopamine and serotonin neurotransmitter signaling. Consistent with these findings, we identified a significant alteration in cortical PSD-95 expression, a PDZ-containing protein that has been shown to be involved in postsynaptic signal transduction. Together, our observations indicate an important role for Npas3 in controlling normal brain development and neurosignaling pathways.
引用
收藏
页码:1265 / 1276
页数:12
相关论文
共 54 条
[1]   The HD mutation causes progressive lethal neurological disease in mice expressing reduced levels of huntingtin [J].
Auerbach, W ;
Hurlbert, MS ;
Hilditch-Maguire, P ;
Wadghiri, YZ ;
Wheeler, VC ;
Cohen, SI ;
Joyner, AL ;
MacDonald, ME ;
Turnbull, DH .
HUMAN MOLECULAR GENETICS, 2001, 10 (22) :2515-2523
[2]   Hippocampal modulation of sensorimotor processes [J].
Bast, T ;
Feldon, J .
PROGRESS IN NEUROBIOLOGY, 2003, 70 (04) :319-345
[3]   The serotonin 5-HT2A and 5-HT2C receptors interact with specific sets of PDZ proteins [J].
Bécamel, C ;
Gavarini, S ;
Chanrion, B ;
Alonso, G ;
Galéotti, N ;
Dumuis, A ;
Bockaert, J ;
Marin, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (19) :20257-20266
[4]   Characterization of Npas3, a novel basic helix-loop-helix PAS gene expressed in the developing mouse nervous system [J].
Brunskill, EW ;
Witte, DP ;
Shreiner, AB ;
Potter, SS .
MECHANISMS OF DEVELOPMENT, 1999, 88 (02) :237-241
[5]   INTERACTIONS BETWEEN GLUTAMATERGIC AND MONOAMINERGIC SYSTEMS WITHIN THE BASAL GANGLIA - IMPLICATIONS FOR SCHIZOPHRENIA AND PARKINSONS-DISEASE [J].
CARLSSON, M ;
CARLSSON, A .
TRENDS IN NEUROSCIENCES, 1990, 13 (07) :272-276
[6]  
Carter RJ, 1999, J NEUROSCI, V19, P3248
[7]   Genetic heterogeneity in schizophrenia II: conditional analyses of affected schizophrenia sibling pairs provide evidence for an interaction between markers on chromosome 8p and 14q [J].
Chiu, YF ;
McGrath, JA ;
Thornquist, MH ;
Wolyniec, PS ;
Nestadt, G ;
Swartz, KL ;
Lasseter, VK ;
Liang, KY ;
Pulver, AE .
MOLECULAR PSYCHIATRY, 2002, 7 (06) :658-664
[8]  
Clark RE, 2000, J NEUROSCI, V20, P8853
[9]   Abnormalities of the NMDA receptor and associated intracellular molecules in the thalamus in schizophrenia and bipolar disorder [J].
Clinton, SM ;
Meador-Woodruff, JH .
NEUROPSYCHOPHARMACOLOGY, 2004, 29 (07) :1353-1362
[10]   Altered transcript expression of NMDA receptor-associated postsynaptic proteins in the thalamus of subjects with schizophrenia [J].
Clinton, SM ;
Haroutunian, V ;
Davis, KL ;
Meador-Woodruff, JH .
AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (06) :1100-1109